eXoZymes (NASDAQ:EXOZ) Issues Earnings Results

eXoZymes (NASDAQ:EXOZ) released its quarterly earnings data on Thursday. The company reported ($0.28) EPS for the quarter, FiscalAI reports.

eXoZymes Price Performance

EXOZ traded down $0.12 during midday trading on Friday, reaching $9.76. 125 shares of the company’s stock were exchanged, compared to its average volume of 4,091. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.51 and a quick ratio of 2.51. The stock has a market capitalization of $82.76 million, a PE ratio of -9.04 and a beta of 2.85. The business’s 50-day moving average price is $9.06 and its 200 day moving average price is $11.10. eXoZymes has a 1-year low of $7.08 and a 1-year high of $18.40.

eXoZymes Company Profile

eXoZymes, Inc develops, manufactures and supplies a range of enzymes and reagents designed for molecular biology research and diagnostic applications. The company’s enzyme engineering platform underpins a portfolio of products aimed at supporting nucleic acid purification, amplification and analysis workflows.

Key offerings from eXoZymes include magnetic bead–based nucleic acid extraction kits, DNA polymerases, reverse transcriptases, proteases and custom enzyme services. In addition, the company provides molecular diagnostic test kits designed for pathogen detection, leveraging scalable production processes and quality systems aligned with regulatory standards.

eXoZymes serves academic research institutions, biotechnology and pharmaceutical companies, and clinical diagnostic laboratories worldwide.